These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12914005)

  • 1. [The role of Helicobacter pylori and NSAIDS in upper gastrointestinal disease].
    Hu FL
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):722-3. PubMed ID: 12914005
    [No Abstract]   [Full Text] [Related]  

  • 2. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and non-malignant diseases.
    Kupcinskas L; Malfertheiner P
    Helicobacter; 2005; 10 Suppl 1():26-33. PubMed ID: 16178968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cause-targeted treatment of ulcer disease].
    Seppälä K; Sipponen P; Palmu A
    Duodecim; 1994; 110(20):1853-9. PubMed ID: 7555798
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs.
    Jones MP
    J Psychosom Res; 2006 Apr; 60(4):407-12. PubMed ID: 16581366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer after H pylori.
    Heatley RV
    Practitioner; 2000 Oct; 244(1615):899-901, 903. PubMed ID: 11116737
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of peptic ulcer disease.
    Beales IL
    Practitioner; 2004 Jul; 248(1660):524-9. PubMed ID: 15255413
    [No Abstract]   [Full Text] [Related]  

  • 10. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and non-malignant diseases.
    Shirin H; Leja M; Niv Y
    Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori: a historical perspective 1983-2003.
    Fraser A
    N Z Med J; 2004 May; 117(1194):U896. PubMed ID: 15156214
    [No Abstract]   [Full Text] [Related]  

  • 16. Helicobacter pylori and NSAIDS--more questions than answers.
    Ryan MJ
    Am J Gastroenterol; 1991 Aug; 86(8):1090-1. PubMed ID: 1858749
    [No Abstract]   [Full Text] [Related]  

  • 17. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 20. NSAID disorders in the esophagus, stomach and duodenum have been an important topic for a long time. Foreword.
    Terano A
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():Siv. PubMed ID: 20586877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.